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FBI-1 is a cellular POZ-domain–containing protein that binds to the HIV-1 LTR and associates
with the HIV-1 transactivator protein Tat. Here we show that elevated levels of FBI-1 specifically
stimulate Tat activity and that this effect is dependent on the same domain of FBI-1 that mediates
Tat-FBI-1 association in vivo. FBI-1 also partially colocalizes with Tat and Tat’s cellular cofactor,
P-TEFb (Cdk9 and cyclin T1), at the splicing-factor–rich nuclear speckle domain. Further, a
less-soluble population of FBI-1 distributes in a novel peripheral-speckle pattern of localization as
well as in other nuclear regions. This distribution pattern is dependent on the FBI-1 DNA binding
domain, on the presence of cellular DNA, and on active transcription. Taken together, these
results suggest that FBI-1 is a cellular factor that preferentially associates with active chromatin
and that can specifically stimulate Tat-activated HIV-1 transcription.
INTRODUCTION
The HIV-1 promoter can generate two types of RNA mole-
cules (Kao et al., 1987; Ratnasabapathy et al., 1990; Sheldon et
al., 1993). In the absence of the viral transactivator protein,
Tat, the majority of the molecules are stable, short, non-
polyadenylated transcripts, and the minority are full-length,
polyadenylated transcripts. The short transcripts correspond
to RNAs with heterogeneous 3 ends located around posi-
tion 60 and contain the TAR element, the binding site for
Tat. In the presence of Tat, the amount of short transcripts is
decreased and the amount of full-length transcripts is dra-
matically increased (Tat reviewed in Karn, 1999). Tat binds
to the TAR along with a cellular cofactor complex, TAK
(Herrmann and Rice, 1993; Herrmann and Rice, 1995). TAK
is one form of P-TEFb that contains Cdk9 and Cyclin T1
(Figure 1). P-TEFb is an elongation factor of RNA polymer-
ase II (pol II) that phosphorylates the pol II carboxy terminal
domain (CTD; reviewed in Price, 2000). CTD phosphoryla-
tion leads to the dissociation of negative elongation factors
like NTEF (Price, 2000) or NELF (Yamaguchi et al., 1999) and
the stimulation of pol II elongation competence. Thus, Tat-
TAK associates with the TAR, which leads to the phosphor-
ylation of the CTD, the dissociation of negative elongation
factors, and the increased elongation competence of the
HIV-1 transcription complexes.
In the absence of Tat, efficient synthesis of the short tran-
scripts is dependent on a bipartite DNA element, known as
the inducer of short transcripts (IST, Figure 1), located just
downstream of the start site of transcription (Ratnasabapa-
thy et al., 1990; Sheldon et al., 1993; Pendergrast et al., 1996;
Pendergrast and Hernandez, 1997). IST activates transcrip-
tion from the HIV-1 promoter, but the resulting RNAs are
short. Thus, IST seems to stimulate the formation of tran-
scription complexes that are not capable of efficient elonga-
tion.
A cellular factor that binds in vitro to the IST element, but
not to IST mutants, has been purified and cloned (Pessler et
al., 1997; Morrison et al., 1999). This factor, called FBI-1
(factor that binds to IST), is a Kruppel-type zinc finger
protein that contains at its N-terminus a POZ (for poxvirus
and zinc fingers) domain (Bardwell and Treisman, 1994;
Albagli et al., 1995). The POZ domain is a 120-amino acid
conserved motif that is often located at the N-terminus of
Kruppel-type zinc finger transcription factors. FBI-1 was
independently cloned as part of a screen for proteins con-
taining POZ domains (LRF, Davies et al., 1999) and as a
protein that is strongly expressed in osteoclasts (OCZF, Ku-
kita et al., 1999). Some POZ proteins such as PLZF, BCL6,
and GAF are transcription factors associated with chromatin
remodeling capabilities (Dhordain et al., 1997; Hong et al.,
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1997; Wilkins and Lis, 1997; David et al., 1998; Huynh and
Bardwell, 1998; Huynh et al., 2000). POZ proteins form ho-
momers and heteromers via the POZ domain and often
display punctate nuclear localization patterns (Dhordain et
al., 1995). Indeed, FBI-1 has been shown to self-associate via
both its POZ domain (Davies et al., 1999; Morrison et al.,
1999) and its zinc finger (ZF) domain (Morrison et al., 1999)
and to heteromultimerize with BCL-6 via POZ and ZF do-
mains (Davies et al., 1999). In addition, overexpressed FBI-1
shows a punctate nuclear localization pattern (Davies et al.,
1999), although the localization of endogenous FBI-1 has not
been reported.
FBI-1 binds to IST and associates with HIV-1 Tat in coim-
munoprecipitation assays, linking it to the HIV-1 promoter
(Morrison et al., 1999). However FBI-1 has not been func-
tionally linked to either short transcript production or Tat
activation. Also its cellular function has not been elucidated.
Here we show that elevated levels of FBI-1 significantly and
specifically stimulate Tat activity and that this effect is de-
pendent on the same domain of FBI-1 that mediates Tat-
FBI-1 association. Also endogenous FBI-1 partially colocal-
izes with both Tat and endogenous P-TEFb (Cdk9 and
Cyclin T1) within the splicing-factor–rich nuclear speckle
domain, and this colocalization is dependent on the same
domain necessary for Tat association and stimulation. In
addition, a subpopulation of FBI-1 displays a novel periph-
eral-speckle pattern of localization that probably corre-
sponds to regions of active chromatin. These results suggest
a functional link between FBI-1 and Tat-activated HIV-1
transcription and that FBI-1 is preferentially associated with
active chromatin in mammalian cells.
MATERIALS AND METHODS
Plasmid Constructs
All of the T7 and HA-tagged constructs expressing FBI-1 and Tat
have been described previously (Morrison et al., 1999). pHIV-1/Luc
was constructed by amplifying HIV-1 promoter sequences from
159 to 80 and ligating this fragment into pGL3-Basic vector
(Promega, Madison, WI) cut with Asp718 and HindIII. Likewise,
pHIV-1/SLIIB/Luc was constructed by amplifying HIV-1 promoter
sequences from 159 to 80 from pHIV-1/R/SLIIB (Pendergrast
and Hernandez, 1997) and ligating this fragment into pGL3-Basic
vector cut with Asp718 and HindIII. pRL-gl-enh was constructed
by inserting by ligation the PCR-derived -globin promoter se-
quences from H1/gl (Ratnasabapathy et al., 1990) into the BglII-
SalI–digested pRL-null vector (Promega). The resulting constructs
were sequenced to ensure the fidelity of the PCR. For FBI-1-EGFP–
expressing construct, EGFP coding sequences were amplified by
PCR from a PBS-derived EGFP vector (a kind gift of M. Greenberg)
with primers that place BglII sites at both ends of the gene and
inserted by ligation into pCGN-FBI-1 digested with BglII. The re-
sulting construct was sequenced to ensure that no point mutations
were introduced during PCR and expression was checked by im-
munoblot (our unpublished results). FBI-1-EGFP was tested in a
luciferase assay for activity and found to be able to stimulate Tat
activity as well as wild-type FBI-1 (our unpublished results). pcRev,
pcRev-VP16, and pcTat-Rev were kind gifts from B. Cullen.
Antibodies
The cyclin T1 and Cdk9 rabbit polyclonal antibodies used were the
kind gift of D. Price (University of Iowa). They were both used at a
dilution of 1:100 but similar results were seen for both at dilutions
of 1:50 and 1:250 (our unpublished results). We also saw similar
results with a rabbit polyclonal from Santa Cruz Biotechnology
(Santa Cruz, CA) for Cdk9 (dilution 1:100) and a goat polyclonal
from Santa Cruz for cyclin T1 (dilution 1:50; our unpublished re-
sults). Speckles were detected with human polyclonal ANA-S anti-
body (Sigma, St. Louis, MO) at a 1:100 dilution and with a mouse
mAb specific for splicing factor SC35 (Sigma and also a kind gift
from D. Spector), used at a 1:1000 dilution. HA-tagged proteins
were detected with the mouse mAb 12CA5 (Niman et al., 1983) and
T7-tagged proteins were detected with T7-Tag Antibody (Novagen,
Madison, WI), both used at a dilution of 1:1000, but similar results
were seen with 12CA5 as high as 1:3000 and with T7-Tag as high as
1:5000 (our unpublished results). HA-Tat was also visualized with
the mAb 1975 procured from the NIH AIDS Research and Reference
Reagent Program and showed aberrant nucleolar staining at multi-
ple dilutions ranging from 1:50 to 1:1000 (our unpublished results).
FBI-1 was detected with similar results using rabbit polyclonal
antibodies 413 and 415, raised from two separate FBI-1 peptides
(Morrison et al., 1999) at dilutions ranging from 1:100 to 1:1000 with
1:500 depicted for both. Primary antibodies were detected using the
appropriate secondary antibodies conjugated to FITC or Texas Red
(Jackson ImmunoChemicals, West Grove, PA; dilution 1:300).
Immunolabeling
For immunolabeling, either untransfected cells or cells transfected
as described (Pendergrast and Hernandez, 1997) were grown on
coverslips and fixed in 2% freshly prepared formaldehyde in PBS
for 10 min at room temperature (RT). Cells were permeabilized in
PBS  0.4% Triton X-100 for 10 min at RT and then washed three
times for 10 min each in PBS. For the experiments depicted in Figure
4 the same results were seen when the fixing and permeabilization
were performed simultaneously with 2% formaldehyde  0.4%
Triton X-100 for 10 min at RT or when 1% normal goat serum
(Jackson ImmunoChemicals) was included in all of the washes (our
unpublished results). To detect less-soluble protein, cells were
washed once briefly with ice-cold PBS and then extracted with CSK
Figure 1. (A) Schematic diagram of the insert for the reporter
constructs pHIV-1/TAR/Luc and pHIV-1/SLIIB/Luc containing
HIV-1 sequences from 157 to 82, a region that includes 1) the
HIV-1 promoter with the enhancer (ENH), the three Sp1 binding
sites, and the TATA box and 2) R sequences from positions 1 to
82 with IST sites and the TAR. The SLIIB insert (B) is described in
Tiley et al. (1992). (B) Schematic diagram showing the sequence of
the TAR and SLIIB inserts. Tat binds to TAR along with its cellular
cofactors CDK9 and Cycling T. Replacement of TAR with SLIIB
allows the targeting of Rev fusion proteins such as Rev-VP16 to the
R region.
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buffer (150 mM NaCl, 300 mM sucrose, 10 mM PIPES, pH 6.8, 3
mM MgCl2, 1 mM PMSF)  0.4% Triton X-100 for 3 min on ice
and then fixed with 2% formaldehyde in PBS for 10 min at RT.
After washing, the coverslips were incubated with primary an-
tibody in PBS for 1 h at RT. Cells were then rinsed in PBS three
times for 10 min at RT and then incubated with secondary
antibody for 45 min at RT. Cells were then washed three times in
PBS for 10 min at RT, with the final wash containing 1 g/ml
4,6-diamidino-2-phenylindole (DAPI) where appropriate. The
coverslip was then mounted onto glass sides with Vectashield
(Vector Laboratories, Burlingame, CA) mounting media or with
90% glycerol in PBS with 1 mg/ml paraphenylenediamine as an
antifade agent, adjusted to pH 8.0 with 0.2 M bicarbonate buffer.
Cells were examined either with a Zeiss LSM 510 confocal mi-
croscope equipped with an argon-krypton laser or with a Zeiss
(Thornwood, NY) Axiovert microscope equipped with epifluo-
rescence and differential interference contrast optics. A SenSys
cooled charge-coupled device camera (Photometrics, Tuscon AZ)
captured images with the use of Metamorph Image software
(Universal Imaging Corp., West Chester, PA). Multiple images
containing several cells were collected and representative cells
are shown. All images were digitally processed for presentation
using Adobe PhotoShop (Adobe Systems, San Jose, CA).
Nuclease Digestion
Cells were CSK  0.4% Triton X-100 extracted for 3 min on ice,
rinsed gently in PBS (pH 7.4), and incubated in either DNase I (100
g/ml in PBS  5 mM MgCl2, RNase free)  0.5 U/l RNasin,
RNase A (100 g/ml in PBS, DNase free), or PBS  5 mM MgCl2
only for 30 min at 37°C. Similar results were seen for all three
treatments with a 30-min RT incubation. After three washes in PBS,
cells were fixed and prepared for immunolabeling as above.
In Vivo Immunoprecipitations
Three micrograms of pCGN or pCGT plasmids, either empty or
expressing FBI-1 or Tat as indicated, were transfected into HeLa
cells by electroporation as described (Pendergrast and Hernandez,
1997). Extract preparation, immunoprecipitations and immunoblot-
ting were performed as described (Pendergrast and Hernandez,
1997). In all cases control immunoblots were performed to ensure
equal expression and immunoprecipitation of mutant proteins. IPs
and washes were performed in the presence of 75 g/ml ethidium
bromide to inhibit protein–DNA interaction.
Luciferase Assays
Two micrograms of the Firefly Luciferase reporter plasmid pHIV-
1/Luc, 500 ng of the internal control reporter plasmid pRL-gl-
enh, and either a control expression vector or a vector expressing
the indicated protein were transfected into HeLa cells by electropo-
ration as previously reported (Pendergrast and Hernandez, 1997).
Similar results were also seen using 800 ng of the pRL-TK (Promega)
control promoter. Twenty-four hours posttransfection the cells were
harvested, and extract was prepared using Promega Passive Lysis
Buffer and the Promega Dual Luciferase kit protocols. The extract
was analyzed with the Bioscan Mini-Lum Luminometer (Washing-
ton, DC). Each experiment was performed three times with separate
transfections, and the results shown are the average of those exper-
iments.
RESULTS
FBI-1 Can Stimulate Tat Activity
FBI-1 binds to the HIV-1 promoter and interacts with HIV-1
Tat in coimmunoprecipitation assays (Morrison et al., 1999),
suggesting that it may have some effect on Tat transactiva-
tion. To explore this possibility, we tested the effect of tran-
sient overexpression of FBI-1 on HIV-1 transcription in vivo,
using a Dual Luciferase Reporter System (Promega). We
cotransfected into HeLa cells: a construct containing the
HIV-1 promoter upstream of a Firefly Luciferase reporter
gene (Figure 1), a construct containing the -globin pro-
moter upstream of the Renilla Luciferase reporter gene as an
internal control, and plasmids expressing HA-FBI-1 and/or
HA-Tat. Twenty-four hours posttransfection we harvested
the cells and assayed for Luciferase activity as a measure of
transcriptional activity. Figure 2A shows the HIV-1 Firefly
Luciferase activity normalized to the -globin Renilla Lucif-
erase activity. Cotransfection of the HA-FBI-1 expression
construct lead to a strong increase in Tat activity (Figure 2A,
5-fold), whereas basal HIV-1 promoter activity was only
weakly affected (2-fold). In contrast, overexpression of the
transactivator Oct 1 had little effect on either basal or Tat-
activated transcription. Another POZ protein, HA-BCL6,
slightly repressed transcription as has been reported (Baron
et al., 1997). Immunoblot analysis confirmed that Tat expres-
sion levels were unaffected by FBI-1 overexpression and that
FBI-1, BCL6, and Oct 1 expression levels were comparable
(our unpublished results). Similar results were obtained
with HeLa cells containing an integrated HIV-1-Luciferase
construct and in transient transfection experiments per-
formed in Jurkat and 293 cells (our unpublished results). In
another set of experiments, using lower amounts of plas-
mids expressing truncated FBI-1 mutants, we determined
that both the POZ and especially the Zinc Finger (ZF) do-
main of FBI-1 (Figure 2B) were required for the full effect on
transcription (Figure 2C). Again, immunoblot analysis con-
firmed that the expression plasmids for full-length FBI-1
(FL), and FBI-1 with either the POZ domain (POZ) or the
ZF domain (ZF) deleted yielded similar amounts of protein
(our unpublished results). The observation that FBI-1 more
strongly activates Tat-activated transcription than basal
transcription suggests that the effect is Tat specific. To de-
termine if this is so for activated transcription, we replaced
the TAR sequences in pHIV-1/Luc with a 13-base pair se-
quence derived from the Rev response element that consti-
tutes an efficient RNA target for Rev binding in vivo, exactly
as described by Tiley et al. (1992). The resulting construct is
shown in Figure 1. We then used this construct to determine
if FBI-1 could enhance the activation of Rev-VP16, a fusion
protein known to activate HIV-1 transcription equipped
with such a modified TAR (Tiley et al., 1992; Madore and
Cullen, 1995). As expected, neither Rev nor Tat significantly
stimulated transcription from this construct (Figure 2D).
However expression of the Tat-Rev fusion protein signifi-
cantly stimulated transcription (13-fold), and this activated
transcription was strongly enhanced by coexpression of
FBI-1 (5-fold). Rev-VP16 could also activate transcription
albeit at a lower level (4.8-fold) than Tat-Rev. Interestingly,
FBI-1 could not significantly enhance activation by Rev-
VP16. In other experiments, FBI-1 did not significantly affect
activation by Rev-Rel or Rev-Sp1 (our unpublished results).
These data show that increasing the amount of FBI-1 in the
cell specifically enhances Tat activation of the HIV-1 pro-
moter, suggesting that FBI-1 modulates Tat-activated HIV-1
transcription.
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FBI-1 Associates with Wild-type but not
Activation-deficient Tat via Its ZF Domain in Vivo
In Luciferase assays, deletion of the POZ domain reduces
FBI-1’s stimulatory effect on Tat transactivation, and dele-
tion of the ZF region nearly abolishes the effect. Because
FBI-1 has been shown to associate in vivo with Tat, we
decided to determine the region(s) of FBI-1 that are neces-
sary for this association. To do this, we transiently expressed
HA-tagged HIV-1 Tat alone or together with T7-tagged full-
length or truncated derivatives of FBI-1 (Figure 2B) in HeLa
cells. Protein extracts from these lysed cells were used for
nondenaturing immunoprecipitations (IPs) with anti-HA
antibodies, and the immunoprecipitates were checked for
the presence of the T7-tagged derivatives of FBI-1 by SDS-
PAGE fractionation and immunoblotting with anti-T7 anti-
body. As shown in Figure 3A, in the absence of coexpressed
HA-Tat, anti-HA antibody immunoprecipitates did not con-
tain T7-tagged full-length FBI-1 (FL) nor the POZ, C-ter-
minal ZF-containing-region (ZF, Figure 2B) and ZF trun-
cations, demonstrating that the anti-HA antibody does not
cross-react with any of the T7 tagged FBI-1 proteins (lanes
2–5). However, when HA-Tat was coexpressed with the
T7-FBI-1 derivatives, the anti-HA immunoprecipitates con-
tained FL, POZ, and ZF FBI-1, but not ZF FBI-1 (lanes
6–9). An additional immunoblot confirmed that all the T7-
FBI-1 derivatives were expressed at similar levels (Figure
3B). Thus, the ZF region of FBI-1 is necessary and sufficient
for in vivo association with Tat.
Full-length FBI-1 does not associate efficiently with Tat
mutants defective in transcriptional activation (Morrison et
al., 1999). To determine if this holds true for the ZF fragment,
HeLa cells were transfected with a wild-type T7-tagged ZF
construct, either alone or together with wild-type or mutant
HA-Tat expression constructs. The resulting lysates were
then used for nondenaturing IPs with anti-HA antibody. As
above, starting material and immunoprecipitated proteins
were fractionated by SDS-PAGE and immunoblotted with
Figure 2. Expressed FBI-1 FL synergizes with HIV-1 Tat at the
HIV-1 LTR. (A, C, and D) HeLa cells were transiently transfected
with 2 g of the reporter plasmids HIV-1/TAR/Luc (A and C) or
HIV-1/SLIIB/Luc (D), along with empty expression vector (No
FBI-1) or the indicated HA-tagged expression plasmids at 1 and
3 relative amounts. The amounts of expression plasmids (100–900
ng) were calibrated to express equal amounts of proteins as judged
by anti-HA immunoblot (our unpublished results). Amounts trans-
fected were as follows: For (A) 100 ng of pcgn Tat, 200 ng (1) and 600
ng (3) pcgn FBI-1 FL, 100 ng (1) and 300 ng (3) pcgn Oct 1, 300 ng (1)
and 900 ng pcgn (3) BCL6; for (C) 100 ng Tat, 200 ng (1) and 600 ng
(3) pcgn FBI-1 FL and ZF and 150 ng (1) and 450 ng (3) pcgn POZ;
for (D) 500 ng FBI-1 FL, 500 ng pcRev, 100 ng pcgn Tat, 500 ng
pcTat-Rev, and 800 ng pc Rev-VP16. 500 ng of -globin-Renilla
expression vector was cotransfected as an internal control for trans-
fection. Depicted activation levels are the results of three indepen-
dent experiments, are normalized to -globin expression, and are
relative to No FBI-1,  Tat levels arbitrarily set to 1. Error bars
represent SD calculated by Microsoft Excel. (B) FBI-1 and FBI-1
mutant constructs. FL FBI-1 corresponds to FBI-1 amino acids 1–584;
POZ, amino acids 122–584; ZF, amino acids 377–584; ZF1, FL FBI-1
with the mutations C384A  C387A; ZF2, FL FBI-1 with the muta-
tions C412A  C415A; ZF3, FL FBI-1 with the mutations C440A 
C443A; ZF4, FL FBI-1 with the mutations C468A  C471A; ZF,
amino acids 1–382 and 485–584.
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the anti-T7 antibodies. As shown in Figure 3C, equal
amounts of T7-ZF were expressed in all four transfections
(lanes 1–4). A small amount of T7-ZF was detected in the
anti-HA immunoprecipitate from cells transfected with
T7-ZF alone, probably because of a small amount of protein
sticking nonspecifically to the beads (lane 5). The coexpres-
sion of HA-Tat with T7-ZF lead to a strong increase in the
amount of coimmunoprecipitated T7-ZF (lane 6). In contrast,
the coexpression of T7-ZF and the transactivation-defective
mutant HA-Tat derivatives HA-Tat18IS (Rice and Carlotti,
1990a, 1990b; Morrison et al., 1999) and HA-TatC30, 31A
(Rice and Carlotti, 1990a; Morrison et al., 1999) did not
increase immunoprecipitated ZF levels over background
(lanes 7 and 8), consistent with the results previously seen
with FL FBI-1 (Morrison et al., 1999). The observation that
the same point mutations in Tat that prevent the interaction
with FL FBI-1 also prevent interaction with FBI-1 ZF sug-
gests that the interaction is specific and does not reflect a
general stickiness of the proteins involved. In addition, be-
cause the IP’s were performed in the presence of ethidium
bromide, the FBI-1-Tat interaction was probably not medi-
ated by contaminating DNA. We conclude that FBI-1 asso-
ciates with Tat via its ZF domain in vivo, the very same
domain required for maximal enhancement of Tat activity.
FBI-1 Partially Colocalizes with Tat and Tat’s
Cofactor, P-TEFb (Cyclin T1 and Cdk9), in the
Splicing-factor–rich Nuclear Speckles
We have shown that FBI-1 associates in vivo with Tat and
that elevated levels of FBI-1 stimulate Tat’s activity. To
further analyze the association of FBI-1 and Tat in the con-
text of intact cell nuclei, the subcellular localization of FBI-1
and Tat were compared. HeLa cells were transfected with a
construct that expresses HA-Tat, and the localization of
endogenous FBI-1 and HA-Tat was examined using double-
labeling immunofluorescence with anti-FBI-1 and anti-HA
antibodies. The results show that the endogenous FBI-1 was
localized predominantly to the nucleus with a minimal la-
beling in the nucleolus and the cytoplasm (Figure 4A). The
nuclear distribution is heterogeneous with numerous signal
foci of varying sizes and shapes in addition to more diffuse
nucleoplasmic staining. This pattern was observed in the
majority of cells, with two antibodies raised against different
FBI-1 peptides (Morrison et al., 1999), and with different
fixation methods and antibody dilutions (our unpublished
results, see MATERIALS AND METHODS). HA-Tat immu-
nolabeled with anti-HA antibody also demonstrated a
speckled distribution in addition to areas of diffuse staining
throughout the nucleoplasm. There was little detectable la-
beling in the nucleolus in the majority of cells. In addition to
the anti-HA tag labeling, this pattern of Tat staining was also
observed in cells expressing T7-tagged Tat (our unpublished
Figure 3. The ZF domain of FBI-1 is necessary and sufficient for
Tat association in vivo. (A) Constructs expressing T7FL, T7POZ,
T7ZF, or T7ZF and HA-Tat were expressed alone or in combina-
tion as indicated above the lanes into HeLa cells. Thirty-six hours
posttransfection, extracts from transfected cells were prepared and
incubated with protein A-agarose beads cross-linked to anti-HA
12CA5 monoclonal antibodies (lanes 2–9). The immunoprecipitated
proteins were fractionated on a 12.5% SDS-polyacrylamide gel,
transferred to nitrocellulose and blotted with anti-T7 antibody. Lane
1: one tenth the starting material for the T7FL  HA-Tat immuno-
precipitation (IP; lane 6). Lanes 2–9: the IPs. The position of T7FL,
T7-POZ, and T7-ZF are indicated. For lanes 6–9, an anti-HA im-
munoblot of a separate gel demonstrated that the HA-tagged pro-
teins were expressed and immunoprecipitated (our unpublished
results). For lanes 6–9, an anti-T7 immunoblot of a separate gel
loaded with one tenth the starting material for the IP demonstrated
that the mutant proteins were expressed to a similar level (B). (C)
Constructs expressing T7ZF and wild-type HA-Tat, HA-18IS Tat, or
HA-C30, 31A Tat were transfected alone or in combination as indi-
cated above the lanes into HeLa cells. The experiment was per-
formed as in (A). Lanes 1–4 show one tenth the starting materials;
lanes 5–8 show the IPs.
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results), suggesting that this pattern of Tat localization is not
influenced by the epitope tags. A close examination of a
merged image of the Tat and FBI-1 (Figure 4A, Mag.)
showed that Tat and FBI-1 were concentrated in overlapping
areas, predominantly at their nucleoplasmic speckles, al-
though there was a subset of FBI-1 (green) and Tat (red) that
did not overlap. Thus, endogenous FBI-1 and expressed Tat
partially colocalize, consistent with a biologically relevant
association.
The heterogeneous nuclear localization pattern of both
proteins is reminiscent of the “nuclear speckles” domain, a
subnuclear domain where many splicing factors and some
transcription factors are enriched over other nuclear regions
(Spector, 1993; see DISCUSSION and reviewed in Huang
and Spector, 1996a). To determine whether Tat and its cel-
lular cofactor P-TEFb (cyclin T1 and Cdk9) are part of the
nuclear speckle domain, HA-Tat–transfected cells were dou-
ble-labeled with anti–HA-Tat, anticyclin T1, or anti-Cdk9
and an antibody that defines nuclear speckles. To avoid
secondary antibody cross-reaction, two speckle-labeling an-
tibodies were used. The human polyclonal ANA-S (Sigma)
was used in combination with the mouse monoclonal an-
ti-HA antibody, whereas the mouse monoclonal SC35 anti-
body was used in combination with the rabbit polyclonal
antibodies specific for cyclin T1 or Cdk9. HA-Tat predomi-
nantly colocalized with nuclear speckles as defined by the
ANA-S antibody (Figure 4B, panel 1) in foci of similar
shapes and sizes (panel 1, Mag.). Endogenous cyclin T1 and
Cdk9 also showed predominantly nuclear localization with
numerous nucleoplasmic foci (panels 2 and 3). The distribu-
tion patterns for both proteins were similar, although not
identical, to the nuclear speckles distribution pattern ob-
served when double-labeled with SC35 (panels 2 and 3,
Mag.). Similar patterns for both proteins were also observed
using other antibodies specific for each of these proteins (our
unpublished results, see MATERIALS AND METHODS).
These findings demonstrate that HA-Tat, endogenous cyclin
T1, and endogenous Cdk9 are concentrated at the splicing-
factor–rich nuclear speckles, in addition to being distributed
at other nuclear regions.
Because Tat and FBI-1 only partially colocalized, whereas
Tat largely colocalized with the splicing factor–enriched
speckles, we were interested in examining the spatial rela-
tionship between FBI-1 and SC35. A double-labeling exper-
iment with antibodies directed against endogenous FBI-1
and SC35 was performed, and the results are shown in
Figure 4C. FBI-1 foci were less intense at their center than the
foci of Tat, Cdk9, and cyclin T1 (compare Figure 4C, panel 1,
with 4B). However, the FBI-1 signal was clearly more intense
in the vicinity of the stronger SC35 foci. Interestingly, the
less intensely labeled centers of FBI-1 foci often coincided
with the most intensely labeled areas at the centers of the
SC35 speckles (panel 2, arrowheads). Thus, contrary to Tat,
cyclin T1, Cdk9, and other speckle associated proteins the
FBI-1 signal was often enriched at the periphery of individ-
ual speckle foci but was only sometimes enriched at the
center of the speckle.
A Less-soluble Population of FBI-1 Localizes to the
Nuclear Speckle Periphery
To further investigate the nature of FBI-1 distribution, we
extracted HeLa cells with CSK buffer containing 0.4% Triton
X-100 and 150 mM NaCl before fixation and immunostain-
ing (see MATERIAL AND METHODS; Fu and Maniatis,
1990; Spector et al., 1991; Huang and Spector, 1996b). This
gentle extraction before fixation removes the soluble fraction
of nuclear components while leaving less-soluble proteins
intact. The results are shown in Figure 5. As reported pre-
viously, the localization pattern obtained with the SC35
antibody was not significantly altered by the procedure,
although the speckles were less extended and less connected
(compare Figure 5A, column 2, with 3B, column 2). The CSK
treatment more significantly altered the FBI-1 localization
pattern (column 1). The diffuse nucleoplasmic signal and the
labeling at the periphery of the nucleus were, for the most
part, severely reduced (narrow arrowheads). However the
signal in the vicinity of and at the periphery of the SC35
speckles was less affected; thus, these areas were more dis-
tinct than in nonextracted cells (compare Figure 5A, column
1, with Figure 4C, column 1). Interestingly, although extrac-
tion had little affect on the FBI-1 signal at the periphery of
the speckles, the process often strongly reduced the FBI-1
signal at the center of the speckles (wide arrowheads). Thus,
after extraction, FBI-1 displayed staining in the interior of
the nucleus with more intense signal in the vicinity and at
the periphery of SC35 speckles and less-intense signal di-
rectly overlapping the center of the speckles. This intense
labeling at the periphery but not at the center of the larger
SC35 speckles was similar to what was observed in un-
treated cells but more distinct. We call FBI-1’s distribution
pattern “peripheral-speckle-localization.” This pattern was
different from what was observed for Tat, cyclin T1, and
Figure 4 (facing page). FBI-1, HIV-1 Tat, and TAK/P-TEFb localiza-
tion. (A) Epifluorescent image of HeLa cells transfected with HA-Tat
expressing plasmid. FBI-1 (panel 1, green) and HA-Tat (panel 2, red)
colocalize (panels 3 and 4, yellow) at numerous foci within the non-
nucleolar nucleoplasm. Endogenous FBI-1 was detected with a rabbit
polyclonal (413) primary antibody and fluorescein isothiocyanate
(FITC)-conjugated goat anti-rabbit secondary antibody (FITC-GAR).
HA-Tat was detected with a mouse monoclonal (12CA5) primary
antibody and a Texas Red-conjugated Goat anti-mouse secondary an-
tibody (TR-GAM). (B) Epifluorescent image of HeLa cells transfected
with 2 g of HA-Tat expressing plasmid (panel 1) or mock transfected
(2 g of expression vector) HeLa cells (panels 2 and 3). HA-Tat (panel
1, column 1, green), endogenous cyclin T1 (panel 2, column 1, green)
and Cdk9 (panel 3, column 1, green) and nuclear speckles (panels 1–3,
column 2, red) colocalize (panels 1–3, column 3 and 4, yellow) at
numerous irregularly shaped foci within the nonnucleolar nucleo-
plasm. HA-Tat was detected with 12CA5 primary antibody and an
FITC-conjugated goat anti-mouse secondary (FITC-GAM). Cyclin T1
was detected with a rabbit polyclonal (anticyclin T1) antibody and
FITC-GAR secondary. Cdk9 was detected with a rabbit polyclonal
(anti-Cdk9) antibody and FITC-GAR secondary. Nuclear speckles
were detected with a human polyclonal (ANA-S; panel 1) primary
antibody or a mouse monoclonal (SC35) primary antibody and with
Texas Red–conjugated goat anti-human antibody (TR-GAH) and TR-
GAM, respectively. (C) Epifluorescent image of HeLa cells. Endoge-
nous FBI-1 (green) displays a heterogeneous nuclear localization pat-
tern characterized by numerous signal foci that surround and overlap
with the nuclear speckle domain (red). Note that often there is a slight
decrease in signal within a FBI-1 foci that matches the shape of the
corresponding speckle (panel 2, arrowheads). FBI-1 was detected with
413 primary and FITC-GAR secondary antibodies, and nuclear speck-
les were detected with SC35 primary and TR-GAM secondary anti-
bodies.
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Figure 5. Less-soluble FBI-1 displays peripheral-speckle localization. Epifluorescent image of prefixation CSK extracted HeLa cells.
Less-soluble endogenous FBI-1 (green) shows strong signal surrounding and connecting the nuclear speckles (red) but shows a much weaker
signal at the center of many speckles (large arrowheads) and from regions of the nucleus that have no speckles (narrow arrowheads). FBI-1
was detected with 413 primary antibody or with another rabbit polyclonal antibody specific for FBI-1 (415, our unpublished results) and
FITC-GAR secondary antibody. Nuclear speckles were detected with SC35 primary and TR-GAM secondary antibodies. (B) Confocal image
of prefixation CSK extracted Hela cells transfected with 2 g of T7-FBI-1 (FL). T7-FBI-1 (green) signal is enhanced at the periphery of the SC35
nuclear speckles (red). T7-FBI-1 was detected with a mouse monoclonal primary antibody (T7 epitope antibody, Novagen) and FITC-GAM
secondary antibody. Nuclear speckles were detected as in A.
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Cdk9, all of which showed colocalization with SC35 in either
extracted cells (our unpublished results) or untreated cells
(Figure 4B). To our knowledge, the peripheral-speckle-local-
ization pattern is unique among the known speckle-associ-
ated proteins.
To further analyze and resolve the Z axis relationship
between the localization of FBI-1 and SC35, confocal micros-
copy was used to evaluate the labeling pattern of the two
proteins. To achieve an observable signal for FBI-1 for the
confocal studies, we transiently expressed FBI-1 tagged with
the T7 epitope tag (MATERIALS AND METHODS). HeLa
cells were transfected with the expression construct, and
cells were extracted with CSK buffer before fixation so that
the peripheral-speckle localization could be better visual-
ized. The localization of tagged FBI-1 and SC35 were com-
pared using immunolabeling (Figure 5B). Less soluble T7-
FBI-1 was not as limited to certain regions of the nucleus as
was endogenous FBI-1, probably because of overexpression;
however, its signal was stronger in the area at the periphery
of the speckles. Indeed, in some cases the expressed protein
actually formed bright rings against the more diffuse back-
ground signal around the centers of some of the larger SC35
foci. This pattern actually makes it possible to predict, with
reasonable accuracy, the position and shape of the larger
and more defined speckles based on the T7-FBI-1 signal
alone. A similar pattern was observed with FBI-1 tagged
with EGFP (our unpublished results). Together, these results
indicate that there are at least two populations of FBI-1 in the
nucleus, a more soluble population that shows diffuse nu-
cleoplasmic distribution and partial colocalization with nu-
clear speckles, and a less-soluble population that shows a
peripheral-speckle-pattern of localization.
FBI-1 Is Targeted to the Peripheral-Speckled Pattern
by Its Binding to DNA
The peripheral-speckle localization of FBI-1 may be relevant
to past characterization of both speckles and FBI-1, because
previous studies suggest that the regions at the periphery of
speckles are enriched in actively transcribing genes (see
DISCUSSION). Considering the novel nature of less-soluble
FBI-1’s peripheral-speckle localization, we were interested
in determining the mechanism by which FBI-1 is localized to
these regions and the functional implications of this local-
ization.
As a first step toward this goal, a series of truncation and
point mutants of FBI-1 tagged with the T7 epitope were
generated to determine the domain(s) of FBI-1 that are re-
quired for the peripheral-speckle localization (Figure 6C).
HeLa cells were transiently transfected with mutant fusion
proteins and cells were extracted with CSK buffer before
fixation so that the peripheral-speckle localization pattern of
FBI-1 could be more easily evaluated. Deletion of the POZ
domain did not detectably altered the distribution of the
mutant fusion protein compared with the wild-type fusion
protein (compare Figure 6A, panel 1, with Figure 5B). How-
ever, deletion of the zinc finger (ZF) domain resulted in a
significant alteration of the mutant fusion protein’s distribu-
tion. The ZF mutant displayed a much less-intense signal
after extraction (Figure 6A, panel 2, ZF) than the POZ
deletion mutant and was more homogeneously distributed
throughout the nucleoplasm with a rim around the nucleoli
(panel 2, Bright Merge). To further delineate the protein
domain required for the peripheral-speckle distribution, we
examined the localization of mutant proteins containing
point mutations in each of the four zinc fingers. Using the
same mutants, we have previously shown that zinc fingers 1
and 2, but not 3 and 4, are required for FBI-1 binding to
DNA (Morrison et al., 1999). As shown in Figure 6B, muta-
tions in either zinc finger 1 or zinc finger 2 completely
abolished the peripheral-speckle pattern, whereas mutations
in zinc finger 3 or 4 had no effect. Thus, the same two zinc
fingers that are responsible for DNA-binding are required
for targeting FBI-1 to peripheral-speckle regions, suggesting
that DNA binding may be responsible for the peripheral-
speckle localization pattern.
The above results, summarized in Figure 6C, suggest that
FBI-1 is targeted to the peripheral-speckle pattern by bind-
ing to DNA; however, many Kruppel-type zinc finger pro-
teins can also bind RNA and the peripheral-speckle region is
enriched with RNA (Fakan and Puvion, 1980). To distin-
guish whether FBI-1 is localized to the peripheral-speckle
regions by binding to DNA or RNA, we treated permeabil-
ized cells with either DNase I, RNase A, or just buffer. Cells
were then fixed and were double-immunolabeled with anti–
FBI-1 and anti-SC35. DNase I treatment, which dramatically
reduced the DNA content of the cell as seen by DAPI stain-
ing, had no effect on the SC35 nuclear speckles compared
with buffer alone (Figure 7A, panels 1 and 3, column 2).
RNase A treatment also had little affect on the nuclear speck-
les, although the treatment slightly reduced the diffuse nu-
cleoplasmic staining of SC35 and rounded the edges of the
SC35 foci (panel 2, column 2). These observations are con-
sistent with previous studies (Spector et al., 1991). Like SC35,
the peripheral-speckle pattern of endogenous FBI-1 showed
little change when cells were treated with either buffer alone
(panel 1) or with RNase A (panel 2). However, the nuclear
labeling of FBI-1 was nearly abolished when cells were
pretreated with DNase I (panel 3). These findings demon-
strate that the peripheral-speckle distribution of FBI-1 is
dependent on intact DNA and is independent of the pres-
ence of RNA, further supporting the hypothesis that DNA
binding is responsible for its unique nuclear localization
pattern.
As a control, we performed the same experiment concur-
rently on endogenous Cdk9 (Figure 7B) and cyclin T1 (our
unpublished results). Both proteins showed reduced signal
upon treatment with both RNase A and DNase I, but for
both proteins the signal that remained colocalized exten-
sively with SC35. Thus, of the four proteins, only the less-
soluble FBI-1 was affected by DNase I treatment. Together
with the mutagenesis experiments, these data strongly sug-
gest that less-soluble FBI-1 is targeted to the peripheral-
speckle pattern by binding to DNA.
The FBI-1 Peripheral Speckle Pattern Is Dependent
on Active Transcription
There is significant evidence that regions near speckles con-
tain actively transcribing genes (see DISCUSSION). In com-
bination with the results described above, this leads to the
interesting hypothesis that less-soluble FBI-1 is preferen-
tially targeted to actively transcribing DNA near to and at
the periphery of nuclear speckles. To determine the relation-
ship between FBI-1’s peripheral-speckle distribution and the
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Figure 6. The DNA-binding zinc
fingers 1 and 2 are required for
less-soluble FBI-1’s peripheral-
speckle pattern of localization.
Epifluorescent image of prefix-
ation extracted HeLa cells trans-
fected with 2g of the T-FBI-1 mu-
tant-expressing plasmids POZ
(A, panel 1), ZF (A, panel 2), ZF1
(B, column 1), ZF2 (B, column 2),
ZF3 (B, column 3), and ZF4 (B, col-
umn 4). (A) Less-soluble T-FBI-1
POZ (panel 1, green) shows a pe-
ripheral-speckle pattern of local-
ization (Merge), whereas T-FBI-1
ZF (panel 2, green) shows an ab-
errant homogeneous pattern of lo-
calization with an increased signal
from the nucleoli and no increase
in signal near the nuclear speckles
(box 2, red and box 3). The
T-tagged FBI-1 mutants were de-
tected as T-FBI-1 in Figure 4. The
nuclear speckles were detected as
in Figure 5. Bright images result
from 8 exposure times. (B) Less-
soluble T-FBI-1 ZF3 and ZF4 (col-
umns 3 and 4, respectively, green)
also show a peripheral-speckle
pattern of localization; however, T-
FBI-1 ZF1 and ZF2 show aberrant
homogeneous patterns of localiza-
tion (columns 1 and 2, respec-
tively, green). The T-tagged point
mutants were detected as T-FBI-1
in Figure 6. Bright images result
from 10 exposure times. (C)
Summary of results from A and B.
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transcriptional activity of the cell, we examined the distri-
bution of FBI-1 in transcriptionally inhibited cells.
HeLa cells were treated with -amanitin at 50 g/ml, which
strongly inhibits pol II transcription and can release factors that
bind to active chromatin (Hock et al., 1998). After 5 h, we
determined the localization of endogenous FBI-1 and SC35
both with and without extraction. As shown in Figure 8,
-amanitin treatment redistributed SC35 to larger and more
rounded structures (compare column 1 with column 3), con-
sistent with published studies that show that a variety of tran-
scriptional inhibition treatments can cause such an alteration of
the speckle morphology (Spector et al., 1983). Interestingly,
FBI-1, which displayed partial and peripheral colocalization
with SC35 speckles in the absence of -amanitin, was also
redistributed to the enlarged speckles and displayed strong
colocalization with SC35 in unextracted cells (Figure 8, panel 1,
for example, see large arrowhead). However, when cells were
extracted almost all the FBI-1 was lost from the cells (panel 2).
Moreover, the little FBI-1 that was left did not show a periph-
eral-speckle pattern, but rather was more uniformly distrib-
Figure 7. Less soluble FBI-1’s
peripheral-speckle pattern is de-
pendent on cellular DNA but not
on cellular RNA. Epifluorescent
image of prefixation extracted
HeLa cells treated for 30 min at
37°C with either RNase A (A and
B, panel 2), DNase I (A and B,
panel 3), or buffer (A and B, panel
1). (A) FBI-1’s (green) peripheral-
speckle pattern is little disturbed
by treatment with buffer (panel
1) or RNase A (panel 2); how-
ever, less-soluble FBI-1 signal is
drastically reduced upon DNase
I treatment (panel 3, column 1),
whereas the nuclear speckles
(red) are undisturbed. Cdk9, and
nuclear speckles were detected as
in Figure 5. FBI-1 was detected as
in Figure 4. (B) Less soluble
Cdk9’s (green) localization pat-
tern is relatively undisturbed by
all three treatments (column 1)
and still colocalizes (yellow) with
nuclear speckles (red). DNase I
treatment results in a strong re-
duction of DNA content in the
cell as judged by DAPI staining
(A and B, blue)
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uted throughout the nucleoplasm (panel 2, Bright). Thus, the
less-soluble peripheral-speckle pattern is dependent on tran-
scription. This observation, together with the previous immu-
nofluorescence studies suggests that less-soluble FBI-1 is tar-
geted preferentially to actively transcribing DNA at the
periphery of the speckles.
DISCUSSION
FBI-1 and HIV-1 Tat
FBI-1 binds to the HIV-1 promoter, interacts, and partially colo-
calizes with the Tat-TAK/P-TEFb complex, and can increase Tat
activity in a dose-dependent manner. These results suggest that
FBI-1 is involved in HIV-1 transcription. But what is the role of
endogenous FBI-1 in HIV-1 transcription? One possibility is that
FBI-1 acts as a positive modulator of Tat-activated HIV-1 tran-
scription by recruiting Tat/P-TEFb to the promoter via its associ-
ation with Tat. In addition to the association between FBI-1 and
Tat, an enhancing effect could also be due to the binding of FBI-1
to the IST element, an element that stimulates constitutive elon-
gation-incompetent transcription in the absence of Tat and thus
may maintain an open chromatin configuration. Such a promoter
priming effect by a regulator has been described in the regulation
of several heat shock promoters by another POZ protein, GAF
(Wilkins and Lis, 1997). GAF binds to uninduced heat shock
promoters and maintains an open chromatin structure, allowing
the constitutive production of short transcripts and keeping the
promoter primed for induction. Interestingly, a recent study
shows that the Tat cofactor, P-TEFb, is recruited to activated heat
shock loci and is sufficient for induction of the hsp 70 protein (Lis
et al., 2000). Thus, having a POZ protein maintain a region of
open/active chromatin ready for elongation induction by P-TEFb
could be a general mechanism for transcriptional regulation.
Another possibility is that FBI-1 is a negative regulator of
HIV-1 transcription. Although increased levels of FBI-1 en-
hance Tat activity in HeLa cells, we cannot exclude the possi-
bility that the enhancement is due to the sequestering of cofac-
tors of endogenous FBI-1 that normally repress the Tat activity.
This would explain why the POZ mutant of FBI-1 still had a
partial effect on Tat transcription, because deletion mutants
may also act as inhibitors as long as the relevant protein bind-
ing region is intact. Consistent with this hypothesis, FBI-1 can
act as a repressor when targeted to a synthetic promoter (Ku-
kita et al., 1999). Further work will be needed to determine the
mechanism of the FBI-1 effect on Tat activity.
FBI-1 Localizes to a Novel Subnuclear Domain that
Includes the Nuclear Speckles
The nuclear speckles domain is defined by immunofluores-
cence as a subnuclear domain consisting of 10–40 “foci” of
various sizes and shapes to which most splicing factors and
some transcription factors localize (Spector, 1993; reviewed
in Huang and Spector, 1996a; Misteli and Spector, 1998).
Some of the speckles interconnect. Electron microscopic im-
munolabeling with anti-SC35 antibody has demonstrated
that the transcription and splicing factor containing speckles
observed at the light microscopic level correspond to previ-
ously characterized interchromatin granule clusters (IGC)
and perichromatin fibrils (PF; Spector 1993). In vivo H3-
uridine labeling and chase experiments show that perichro-
matin fibrils contain newly synthesized RNA, whereas the
majority of interchromatin granule clusters are not labeled
until several hours after chase. It therefore has been sug-
gested that interchromatin clusters may be depots for the
storage, recycling, or reassembly of transcription and splic-
ing components, whereas the surrounding perichromatin
fibrils are sites of active transcription and RNA processing
(Spector, 1993; Fakan and Modak, 1973). Consistent with this
hypothesis, localization studies of specific promoters have
shown that many abundantly expressed genes are located
near speckles and that pre-mRNA splicing factors are re-
cruited from the speckles to sites of active transcription and
splicing (Huang and Spector, 1991, 1996a; Misteli et al., 1997;
Smith et al., 1999). However, in some cases, highly expressed
genes may recruit large amounts of transcription and splic-
Figure 8. Total FBI-1 is redis-
tributed to enlarged and rounded
nuclear speckles, but the less-sol-
uble FBI-1 population and pe-
ripheral-speckle pattern is drasti-
cally reduced upon inhibition of
transcription. Epifluorescent im-
ages of nonextracted (panel 1)
and prefixation extracted (panel
2) HeLa cells either untreated
(column 1) or treated for 5 h with
50 g/ml of -amanitin (col-
umns 2–4). Total FBI-1 (panel 1,
green) is redistributed into en-
larged nuclear speckles (red and
yellow). Note that unlike in non–
-amanitin–treated cells (Figure
4C), the FBI-1 signal foci match
the shape, size, and relative in-
tensity of the nuclear speckles
even in irregularly shaped foci
(arrowhead). However, less-soluble FBI-1 signal is almost completely lost (panel 2, column 2). A six times longer exposure (panel 2, column
4, Bright) shows that the little FBI-1 that is left after extraction does not show a peripheral-speckle pattern of localization. Nuclear speckles
were detected as in Figure 5. FBI-1 was detected as in Figure 4.
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ing factors in such a manner that the site can enlarge to
resemble a speckle. The IGC has been biochemically purified
and has been found to contain 70 proteins by mass spec-
trometry, including many splicing and some transcription
factors (Mintz et al., 1999). The precise function of this nu-
clear domain remains to be determined.
In this study, we showed that the nuclear localization of
FBI-1 overlaps with the speckled distribution of SC35, al-
though the intensity of FBI-1 labeling tends to be stronger at
the periphery and weaker at the center of the speckles. When
cells were extracted with CSK before fixation, the mild ex-
traction removed most of the FBI-1 signal that was localized
at the center of individual speckles as well as most of the
signal that was diffusely localized throughout the nucleo-
plasm. The remaining less-soluble fraction of endogenous
FBI-1 displayed a novel localization pattern that often coin-
cided with the periphery of the nuclear speckle structure.
This localization pattern is representative of endogenous
protein because immunolabeling using two different anti–
FBI-1 antibodies or the expression of two different epitope-
tagged FBI-1 proteins showed the same pattern. We call this
novel pattern of localization “peripheral-speckle localiza-
tion” to emphasize that FBI-1 is associated with higher af-
finity to the vicinity and periphery of the nuclear speckles.
This association was dependent on FBI-1’s DNA binding
domain, the presence of DNA, and active transcription, sug-
gesting that the localization pattern is the result of FBI-1
association with actively transcribed chromatin. These ob-
servations are consistent with FBI-1 localizing to perichro-
matin fibrils, which have been previously shown to sur-
round interchromatin granule clusters, and to contain active
chromatin and a large amount of newly synthesized RNA.
To our knowledge, FBI-1’s peripheral-speckle pattern of
localization is unique. Instructively, however, two localiza-
tion patterns have been reported that share some aspects of
the FBI-1 pattern. Acetylated histone H3 localizes at foci of
various sizes and shapes that are excluded from the nuclear
periphery, the nucleoli, and the speckles (which is to be
expected as DNA is not present in the speckles; Hendzel et
al., 1998). Treatment of cells with a deacetylase inhibitor,
however, causes an enrichment of signal specifically around
the individual speckles. Given that upon deacetylase inhibi-
tion, transcriptionally active chromatin more rapidly accu-
mulates highly acetylated histones than the rest of the ge-
nome (Covault and Chalkley, 1980; Davie and Hendzel,
1994), the authors suggest that the regions around speckles
contains active chromatin.
The second protein with a localization pattern that shares
a characteristic with FBI-1’s peripheral-speckle pattern is the
nucleosomal binding protein, HMG-17, which can alter the
structure of chromatin and enhance transcription (Bustin et
al., 1995). HMG-17 localizes in irregularly shaped foci that
partially colocalize with active sites of transcription and
with SC35 in most Hep-2 cells (Hock et al., 1998). On treat-
ment of cells with -amanitin, all of the HMG-17 speckles
are redistributed to the enlarged SC35 speckles. Although
the authors did not perform a CSK extraction in the 
amanitin experiment, they did permeabilize the cells and
observed a reduced signal much like the one we saw with
FBI-1 in the extracted -amanitin–treated cells. This argues
that a chromatin bound protein can be released from chro-
matin upon inhibition of transcription by -amanitin.
Given that the regions at the periphery of nuclear speckles
contain active chromatin and that proteins can be released
from chromatin upon inhibition of transcription by -aman-
itin, we suggest the following model for FBI-1 distribution.
FBI-1 exists in two populations. One population is soluble
and resides at the center of the speckles and diffusely
throughout the nucleoplasm, and the other population is
less soluble and consists of FBI-1 bound to transcriptionally
active, peripheral-speckle chromatin. Consistent with this
notion active chromatin is relatively insoluble, possibly be-
cause of an interaction with the nuclear matrix (reviewed by
Davie, 1996; Jackson, 1997). Treatment of cells with -aman-
itin represses transcription, releasing the less-soluble FBI-1
from DNA that then accumulates in the enlarged speckles
(Figure 8, panel 1). However, this unbound protein is now
more soluble and thus is lost upon extraction (panel 2). This
model predicts that FBI-1’s ability to bind DNA may not be
required for targeting the protein to the enlarged transcrip-
tionally independent speckles. Indeed FBI-1 that contains a
mutation that disrupts DNA binding, and peripheral
speckle localization is still recruited to the enlarged speckles
upon -amanitin treatment (our unpublished results).
A question that arises from this model is what targets
FBI-1 to transcriptionally active chromatin that is mostly in
the peripheral-speckle regions? The areas around speckles
are probably enriched in active chromatin, but there is active
chromatin throughout the interior of the nucleus (Hendzel et
al., 1998). Total FBI-1 is present throughout the nucleus and
thus could be targeted to all active chromatin, yet most of
the less-soluble, DNA-dependent, and transcriptionally de-
pendent FBI-1 is preferentially enriched near the speckles.
This may indicate that there are several stages of activated
chromatin and that the peripheral-speckle chromatin repre-
sents a defined stage with some structural difference, per-
haps nuclear matrix association, that makes it and the bound
FBI-1 resistant to extraction.
A second question raised by this model is what is the role of
FBI-1 in peripheral-speckle regions. One possibility is that
FBI-1 contributes to the unique structure of this transcription-
ally active chromatin region as either an activator or a repres-
sor. Indeed, several POZ proteins have been linked to chroma-
tin-remodeling activities (Wilkins and Lis, 1997; Dhordain et al.,
1998). GAF is a transactivator protein at heat shock promoters
capable of maintaining local chromatin in an open conforma-
tion, but also can bind proteins associated with deacetylases
(Espinas et al., 2000). BCL6 and PLZF can bind to the Sin3
deacetylase complex and can repress transcription when tar-
geted to heterologous promoters (Dhordain et al., 1997, 1998;
Hong et al., 1997; David et al., 1998; Huynh and Bardwell, 1998;
Huynh et al., 2000). Thus, FBI-1 may act as an activator or as a
repressor to regulate transcriptionally active chromatin.
Tat and TAK/P-TEFb Colocalize with Nuclear
Speckles
Localization of Tat tagged with two different short peptides, T7
and HA, demonstrated a heterogeneous nuclear localization
pattern that predominantly colocalized with the nuclear
speckle domain (Figure 4 and our unpublished results). We
observed minimal nucleolar labeling. These observations of Tat
distribution are in contrast to some of the published reports
that Tat is predominately localized to the nucleolus by immu-
nolabeling (Cullen et al., 1988; Siomi et al., 1990; Luznik et al.,
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1995). The difference may be due to the expression level of Tat
in different studies.
The Tat cofactor, TAK/P-TEFb (Cyclin T1 and Cdk9), also
predominantly colocalizes to the nuclear speckles (Figure 4).
This finding agrees with the recent deconvolution micros-
copy study of TAK/P-TEFb by Herrmann and Mancini
(2001). The targeting of Tat to this region may facilitate its
interaction with TAK/P-TEFb and the actively transcribing
HIV-1 promoter.
But why is P-TEFb found at the nuclear speckles? The
phosphorylated form of pol II is not efficient at reinitiation
(Gebara et al., 1997). So one possibility is that P-TEFb-pol II
complexes that have finished transcribing their particular
genes accumulate at nuclear speckles for reprocessing and
repackaging so they can be reused at another gene. Consis-
tent with this possibility, the phosphorylated form of RNA
pol II is preferentially found at nuclear speckles, but the
unphosphorylated form is not (Mortillaro et al., 1996). It will
be interesting to see if other processing factors known to
associate with the phosphorylated CTD such as CTD phos-
phatases also localize at speckles.
In summary, we demonstrated that a cellular protein,
FBI-1, specifically stimulates Tat-activated HIV-1 transcrip-
tion. FBI-1 associates with Tat via the zinc finger domain,
and this domain is important for the stimulation of Tat.
Furthermore, we showed that less-soluble FBI-1 localizes to
a unique peripheral-speckled pattern in a DNA binding and
transcription dependent manner, suggesting that FBI-1 pref-
erentially associates with active chromatin.
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